Breaks Categories: News

FridayFeb 13, 2026 12:01 pm

NetworkNewsBreaks – Olenox Industries (NASDAQ: OLOX) Settles Merchant Cash Advance Obligations With Cedar Advance

Olenox Industries (NASDAQ: OLOX) announced it has entered into a mutual settlement and release agreement with Cedar Advance LLC, resolving outstanding amounts owed under previously executed Standard Merchant Cash Advance Agreements. Under the agreement, executed Feb. 10, 2026, Olenox will issue restricted shares of common stock at market price in satisfaction of the obligations, with both parties agreeing to a full release of claims related to the agreements; full terms of the settlement are disclosed in a Form 8-K filed with the Securities and Exchange Commission on Feb. 13, 2026. To view the full press release, visit https://nnw.fm/cbEeY About Olenox Industries Inc. Olenox Industries is a multifaceted energy company focused…

Continue Reading

FridayFeb 13, 2026 11:46 am

NetworkNewsBreaks – ZeroStack Corp. (NASDAQ: ZSTK) Earns First 1 Million 0G Tokens in Staking Rewards

ZeroStack (NASDAQ: ZSTK), an AI-focused asset management company, announced it has earned its first 1 million 0G Tokens in staking rewards since commencing staking activities on Jan. 21, 2026, reflecting an approximate 21% annual percentage yield under current network conditions. Based on an average token price of $0.84 between Jan. 21 and Feb. 2, 2026, the rewards equate to roughly $840,000 for the period, or about $60,000 per day, with approximately 70,000 0G Tokens earned daily. The company said the milestone supports its strategy of deploying capital into yield-generating, AI-focused digital assets, while noting that staking yields are variable and subject to market, protocol, technical and…

Continue Reading

FridayFeb 13, 2026 9:20 am

NetworkNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Launches Upgraded Overwatch Platform for AI-Optimized Drone Telemetry

This article has been disseminated on behalf of SPARC AI Inc.  and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced an upgraded release of SPARC AI Overwatch, a machine learning-driven software platform designed to continuously optimize drone telemetry data and reduce targeting and navigation drift without requiring new hardware. The platform learns drone-specific telemetry patterns through calibration flights and ongoing operational use, applying real-time corrections to improve accuracy, reliability and repeatability across manufacturers and sensor configurations, while strengthening performance as more operational data is collected, positioning Overwatch to support scalable deployment of low-cost drone fleets…

Continue Reading

FridayFeb 13, 2026 9:10 am

NetworkNewsBreaks – Nutex Health Inc. (NASDAQ: NUTX) Reopens Bayou City ER & Hospital in Humble Texas

Nutex Health (NASDAQ: NUTX) announced the reopening of Bayou City ER & Hospital, a 40,000-square-foot facility in Humble, Texas, northeast of Houston, featuring eight emergency room beds, 46 inpatient beds, a full-service laboratory and advanced imaging capabilities including CT, X-ray and ultrasound. Company leadership said the reopening of its largest hospital strengthens access to 24/7 concierge-level care in the Humble and Kingwood areas and supports expansion of specialized services such as behavioral health and medical detox, reinforcing Nutex’s commitment to delivering high-quality, community-focused healthcare. To view the full press release, visit https://nnw.fm/wzmmf About Nutex Health Inc. Headquartered in Houston, Texas and founded…

Continue Reading

FridayFeb 13, 2026 9:00 am

NetworkNewsBreaks – Forward Industries, Inc. (NASDAQ: FWDI) Reports Q1 Fiscal 2026 Results, Details SOL Treasury Expansion

Forward Industries (NASDAQ: FWDI) reported financial and operating results for the fiscal quarter ended Dec. 31, 2025, marking its first full reporting period as a Solana treasury company and highlighting execution of its SOL-focused strategy. The company held 6,962,501 SOL as of quarter end, nearly all staked, generating more than 112,171 SOL in rewards, while revenue increased more than fourfold year over year to $21.4 million, primarily from staking. Results included a $560.2 million loss and $33.0 million impairment on digital assets under U.S. GAAP due to fair value adjustments, contributing to a net loss of $585.6 million, as management…

Continue Reading

ThursdayFeb 12, 2026 3:08 pm

NetworkNewsBreaks – Roth Capital Partners Expands Healthcare Platform with Three Senior Hires 

Roth Capital Partners announced the addition of Jack Terranova as Managing Director, Healthcare Investment Banking, Noah Huehnergarth as Executive Director, Institutional Sales, and Max Masucci as Managing Director and Senior Research Analyst, further strengthening its healthcare platform across investment banking, institutional sales, and equity research. The firm stated the hires enhance its integrated, sector-focused capabilities in life sciences, diagnostics, and therapeutics, supporting capital markets execution, investor connectivity, and strategic growth initiatives, as ROTH has participated in more than 600 healthcare transactions since 2010 totaling over $25 billion in value. To view the full press release, visit https://nnw.fm/hXA28 About ROTH ROTH is a relationship-driven investment bank focused on serving growth companies and their…

Continue Reading

ThursdayFeb 12, 2026 12:58 pm

NetworkNewsBreaks – Sonim Technologies (NASDAQ: SONM) Renames to DNA X, Inc. Following Asset Sale to NEXA(R)

Sonim Technologies (NASDAQ: SONM) changed its corporate name to DNA X, Inc. concurrent with its previously announced asset sale to NEXA(R) formerly Social Mobile. The company stated proceeds from the transaction are expected to fund debt retirement and provide working capital for its digital asset management operations, with DNA X, Inc. moving forward as operator of the DNA X digital asset trading platform acquired in December 2025. The company will temporarily retain the Nasdaq trading symbol SONM, with a planned transition to DNAX in the near future.  To view the full press release, visit https://nnw.fm/zaTfr About DNA X, Inc. DNA X, Inc. is a digital asset management platform,…

Continue Reading

ThursdayFeb 12, 2026 11:01 am

NetworkNewsBreaks – New Pacific Metals Corp. (TSX: NUAG) (NYSE American: NEWP) Reports Fiscal 2026 Second Quarter Results and $41 Million Working Capital

This article has been disseminated on behalf of New Pacific Metals Corp.  and may include paid advertising.  New Pacific Metals (TSX: NUAG) (NYSE American: NEWP) reported a net loss attributable to equity holders of $1.58 million, or $0.01 per share, for the three months ended Dec. 31, 2025, and $2.33 million, or $0.01 per share, for the six months ended Dec. 31, 2025, compared with a net loss of $0.74 million and $2 million, respectively, in the prior-year periods. As of Dec. 31, 2025, the company had working capital of $41 million, while operating expenses for the quarter and six-month period totaled $1.47 million and…

Continue Reading

ThursdayFeb 12, 2026 10:49 am

NetworkNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) CEO Highlights 2026 Clinical Milestones and Strategic Options

Soligenix (NASDAQ: SNGX) issued a shareholder update from President and CEO Dr. Christopher J. Schaber outlining anticipated 2026 milestones across its late-stage rare disease pipeline, including top-line data from the Phase 3 FLASH2 trial of HyBryte™ in early-stage cutaneous T-cell lymphoma expected in the second half of 2026, with an interim analysis approaching in the second quarter and 66 of 80 patients enrolled as of Feb. 10. The letter also reviewed positive Phase 2a data for SGX945 (dusquetide) in Behçet’s Disease published in Rheumatology (Oxford), encouraging Phase 2a psoriasis results for SGX302, ongoing strategic evaluations including partnership and M&A opportunities, and the company’s…

Continue Reading

ThursdayFeb 12, 2026 10:38 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Expands Global Intellectual Property Portfolio Supporting OT-101 Across Neurology and CNS Delivery

Oncotelic Therapeutics (OTCQB: OTLC) and Sapu Bioscience announced key advancements in their global intellectual property portfolio supporting OT-101, a proprietary TGF-β antisense therapeutic platform, with allowed patent claims in Australia covering OT-101 (SEQ ID NO:9) for the treatment of Parkinson’s Disease, including associated sleep-related symptoms, and granted utility model patents in China and Germany for an intracranial continuous infusion delivery device. The company stated the expanded protection spans therapeutic use claims, CNS delivery methods, device-enabled administration and broader oncology and neurology applications, forming an integrated commercialization platform intended to strengthen long-term defensibility, support strategic partnerships and enhance shareholder value, with additional data presentations planned…

Continue Reading